|Podcasts|October 1, 2020
Episode 66: New Approach to Antithrombotics
Author(s)Elaine Quilici
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving patients new hope.
Advertisement
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attacking blood clots from a new angle and are giving patients new hope.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
2
Pfizer and BioNTech Pause Covid Vaccine Study Following Low Enrollment Totals
3
FDA Approves Foundayo Under National Priority Voucher Program
4
The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation
5